ADA 2018 Archives - Clinical Advisor

ADA 78th Scientific Sessions 2018

Empagliflozin Reduces Risk for Nephropathy Regardless of Blood Pressure, LDL Cholesterol, HbA1c

By

July 2, 2018

Investigators examined renal outcomes when controlling cardiovascular risk factors, such as blood pressure, LDL-C, and HbA1c.

ADA 78th Scientific Sessions 2018

Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents

By

Endocrinology Advisor Contributing Writer

July 2, 2018

Investigators analyzed real world data to examine the risk for below-knee amputations in patients with type 2 diabetes taking canagliflozin vs other medications.

Pediatrics Information Center

Metabolic Health Predicative of Cognitive Development in Children

By

Anna Olechowska

July 2, 2018

Researchers assessed whether current metabolic parameters are inversely associated with cognitive functioning.

Diabetes Information Center

Liraglutide May Prevent Dementia in Elderly With Type 2 Diabetes

By

Endocrinology Advisor Contributing Writer

July 2, 2018

Investigators examined the efficacy of liraglutide for the prevention of dementia in elderly patients with type 2 diabetes.

Diabetes Information Center

Age, Baseline HbA1c May Predict Glycemic Control in Newly Diagnosed Type 2 Diabetes

By

Hannah Dellabella

July 2, 2018

Investigators examined the effectiveness of oral agents vs insulin as an initial treatment option for people newly diagnosed with type 2 diabetes.

Endocrinology Information Center

Elevated Triglycerides, Diabetes May Be Predictors of Major Cardiovascular Events

By

Frank J. Connor

July 2, 2018

Investigators examined cardiovascular outcomes in patients with elevated triglyceridemia and diabetes treated with statins.

Diabetes Information Center

Beta-Blockers Show Varied Effects on Hypoglycemic Mortality Risk in Diabetes

By

Endocrinology Advisor Contributing Writer

July 2, 2018

Investigators examined the relationship between the use of β-blockers and incidence of hypoglycemia and risk for mortality in hospitalized patients with diabetes.